Algernon Pharmaceuticals Inc C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N-Dimethyltryptamine (DMT). The Company operates through two segments, which includes the development of repurposed therapeutic drugs in Canada and the facilitation of the Company’s lead drug candidates into off-label phase II clinical trials (humans) in Australia. The Company's pipeline includes NP-251 (Repirinast) and AP-188 (DMT). The Company, through its subsidiary, Algernon NeuroScience Inc., is developing AP-188 (DMT) as a potential treatment for stroke and traumatic brain injury (TBI) recovery. Its NP-251 is being developed as a potential treatment for kidney inflammation and fibrosis.

CSE:AGN - Post by User

Algernon Pharmaceuticals Inc > This drop has no reason

<< Previous

Bullboard Posts

Next >>

Comment by Raddnaron Jul 21, 2020 1:51pm

155 Views

Post# 31297385

RE:RE:This drop has no reason

Raddnar wrote: There is a reason, and it’s simple. Heavy holders are selling their profits, to spark a mild panic sell to drop the price so they can buy more. See this with everything, especially penny stocks. This is how big money beats the little guy. Everyone knows stocks fluxiate, and AGNPF is more prone to that due to the market volatility and low share cost. If you believe in AGNPF, a 5/10% drop with immediate buy increases should scare you. It should excite you. Some one is just grabbing a bigger stake. Hell, I bought more today. It isn’t going to stay below .30 USD for much longer.

Edit: SHOULDN'T scare you.

<< Previous

Bullboard Posts

Next >>

GameSquare’s Stream Hatchet makes the most of Riot Games relationship